Package 68084-343-01

{"route": ["ORAL"], "spl_id": "40052c1b-5558-373b-e063-6394a90ad7d4", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["1af94c80-2b17-409a-98f6-ce00f942351d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-343-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-343-11)", "package_ndc": "68084-343-01", "marketing_start_date": "20191108"}], "brand_name": "Topiramate", "product_id": "68084-343_40052c1b-5558-373b-e063-6394a90ad7d4", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68084-343", "generic_name": "Topiramate", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA078235", "marketing_category": "ANDA", "marketing_start_date": "20191108", "listing_expiration_date": "20261231"}